biologics discovery

Advertent Biotherapeutics, Inc. is a privately held biotechnology company advancing new therapies to help people maintain strength and mobility when muscle is damaged by genetic diseases, injury, or aging. Founded in 2019 as a spin-out from Michigan State University, it combines expertise in growth factor biology, muscle pathology, and drug development to build first-in-class biologics that protect muscle quality over the long term.

drug developmentIND-enabling studiespreclinical developmentstructure-guided protein engineering

Just - Evotec Biologics, wholly owned by Evotec, is a first-to-industry biologics platform company and CDMO that leverages AI/ML technologies and molecular design, cell line development, process intensification and continuous manufacturing strategies to advance biotherapeutics from discovery through clinical stages to commercial launch. It operates J.POD cGMP manufacturing facilities, including J.POD Redmond, Washington, inaugurated in 2021, and has its headquarters in Seattle.

AI/ML technologiescell line developmentcGMP commercial manufacturingchromatographic purificationcontinuous manufacturingdownstream developmentfiltrationformulation developmentin silico molecular optimizationprocess developmenttech transferupstream developmentviral inactivation

Koa Bio develops, scales, and deploys novel therapeutic biologics against multi-drug-resistant bacteria for military and civilian health. Based in Honolulu, Hawaii and Fargo, North Dakota, it works with government agencies, defense research institutions, drug discovery partners, and clinical networks to move biologics from discovery to deployment.

deployment of biologicsmanufacturing scale-up